Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)

Population pharmacokinetics and target attainment of cefepime in critically ill patients and guidance for initial dosing

(2020) Mohammad H. Al-Shaer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study

(2019) L. Boschung-Pasquier et al.   CLINICAL MICROBIOLOGY AND INFECTION

Incidence of nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation

(2018) Biren K. Juthani et al.   HEART & LUNG

Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures

(2018) Gloria Wong et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients

(2018) Vesa Cheng et al.   Expert Opinion on Drug Metabolism & Toxicology

Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens

(2017) Nathaniel J. Rhodes et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia

(2015) Samuel L. Aitken et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic

(2012) Jason A Roberts et al.   BMC INFECTIOUS DISEASES

Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin

(2012) Isabelle K. Delattre et al.   CLINICAL BIOCHEMISTRY

Renal Replacement Therapy in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation

(2012) D. J. Askenazi et al.   Clinical Journal of the American Society of Nephrology

Improving antibiotic dosing in special situations in the ICU

(2012) Janattul-Ain Jamal et al.   Current Opinion in Critical Care

Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation

(2012) Kiran Shekar et al.   JOURNAL OF CRITICAL CARE

Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R

(2012) Michael N. Neely et al.   THERAPEUTIC DRUG MONITORING

ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO

(2012) Kiran Shekar et al.   BMC Anesthesiology

High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function

(2010) F. Lamoth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetic Modeling and Optimal Sampling Strategy for Bayesian Estimation of Amikacin Exposure in Critically Ill Septic Patients

(2010) Isabelle K Delattre et al.   THERAPEUTIC DRUG MONITORING

Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia

(2009) A. M. Nicasio et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS